Leadership

Rose Higgins

MPM, BSN, RN

Chief Executive Officer

Rose has spent her career driving innovation in healthcare, from roles in clinical practice to technology companies. She is committed to finding new ways to leverage technology in delivering better health outcomes.

Prior to Dr.Evidence, Rose was CEO of HealthMyne, a pioneering radiomics company whose IP and technology assets were acquired by Genentech (a Roche company) in 2022. She began her career in nursing at the University of Pittsburgh Medical Center, followed by advancing roles in clinical and care management. Transitioning to leadership in healthcare IT organizations, Higgins took on executive roles with increasing responsibility in organizations including McKesson Corporation and SCIO Health Analytics (acquired by EXL Service Holdings) over a successful 20-year period.

Rose received her Bachelor of Science in Nursing from Duquesne University, and her Master of Public Management from Carnegie Mellon University.

Todd Feinman

MD

Chief Medical Officer, Co-Founder

Todd is dedicated to helping develop AI-enabled technologies that will enable anyone, including patients and doctors, to use real data to make informed healthcare decisions. Todd completed his internship at Cedars-Sinai Medical Center in Los Angeles, and his residency in Internal Medicine at Huntington Memorial Hospital in Pasadena, California. Todd specialized in Hospitalist Medicine, and he helped develop the first Hospitalist programs at FHP Hospital, Queen of the Valley Hospital and Cedars-Sinai Medical Group.

Todd received a BS from UCLA and an MD from UCLA School of Medicine.

Edan Shalev

Chief Technology Officer, Co-Founder

Edan is passionate about driving the convergence of clinical data and technology to generate insights. At Dr.Evidence, Edan oversees the software engineers and architects. His prior experience ranges from developing CAD/CAM software to creating web portals for tier-one pharmaceutical companies. He has worked for a variety of corporations, including TheraCom, where he was responsible for e-commerce systems for physicians, pharmaceutical and biotech manufactures and patient communities.

Edan received his BA from California State University, Northridge.

David Dornstreich

Chief Commercial Officer

David is passionate about building and scaling healthcare technology businesses. As leader of the Business Development, Client Success, Marketing and Revenue Operations teams at Dr.Evidence, he is responsible for developing and implementing a commercial strategy to optimize growth and client experience. Prior to joining Dr.Evidence, David served as Vice President, Strategic Initiatives and Data Partnerships at Veradigm, an Allscripts company, where he focused on biopharma business development, regularly engaging with medical societies, regulatory and government agencies and academic institutions to enrich and extend data content and capabilities.

David holds a BA in Political Science from Hofstra University.

Cathy Finley

MBA

Senior Vice President, Marketing

Cathy is committed to enabling a more equitable healthcare system through technology. A strategic and operational marketing leader, Cathy is responsible for understanding market needs, building awareness and credibility, generating demand, and enhancing client engagement, collaborating with colleagues across Dr.Evidence. With experience from the Fortune 100 to start-ups, including a foundation in consumer products with P&L responsibility at Procter & Gamble, Cathy brings passion and positivity to her role, focusing on empowering everyone with the evidence to make more informed healthcare decisions.

Cathy holds a BBA in Marketing from the University of Texas and an MBA from Purdue University.